Coco Gauff’s Stance on WTA Gene-Testing Policy and Transgender Community

Coco Gauff, a two-time Grand Slam champion, has expressed her thoughts on the WTA Tour’s new gene-testing policy. She recognizes the reasoning behind it but is concerned about the politicization of the issue, which she believes creates unnecessary tension towards the transgender community.

Gauff emphasized the need for a more nuanced discussion, highlighting her own approach to the conversation. After her opening win against Kayla Day at the Canadian Open in Toronto, she spoke to reporters about her views.

So, yes, I guess I kind of agree with trying to protect the fairness in women’s sports. But I also do not like the attack that it is creating, Gauff stated. People who don’t really care, but just want to use this as a reason to attack the trans community — so I’m not really a big fan of that either.

The WTA introduced mandatory one-time gene-testing for all players, requiring testing for the SRY gene. This gene, usually located on the Y chromosome, initiates male sex development and indicates the presence of testes.

The clarity on how many transgender women are participating at the Olympic level, or within the WTA Tour, remains limited. The WTA clarified that the new policy differentiates between biological sex and gender identity, emphasizing that it intends no disrespect or questioning of any person’s identity or dignity.

Critics, including human rights experts and activist groups, have challenged the mandatory screenings, already adopted in track and field, skiing, and boxing. Gauff suggested that the process introduction lacked transparency, noting that some players only learned of the policy upon its announcement.

The WTA’s explanation and Gauff’s response bring attention to the balance between fairness in sports and the rights and dignity of all competitors.